Somatropin (10iu)
Somatropin (10iu)
Couldn't load pickup availability
Overview:
Somatropin is a synthetic analog of human growth hormone (HGH), designed to replicate the structure and biological activity of the 191-amino-acid sequence naturally produced by the pituitary gland. In laboratory settings, Somatropin is widely researched for its role in cellular growth, protein synthesis, metabolism, and tissue repair. Its ability to engage the growth hormone receptor (GHR) makes it a central compound for studying growth-related pathways and metabolic regulation.
In preclinical and controlled clinical environments, Somatropin has been explored for its potential influence on musculoskeletal development, metabolic function, and recovery mechanisms. Research often focuses on developmental deficiencies, catabolic conditions, and metabolic disorders to better understand growth hormone biology. All studies involving Somatropin remain strictly for scientific investigation and are not intended for therapeutic or diagnostic use.
COA
COA
BPC-157 Test Results






Third-Party Testing
Third-Party Testing

What is Somatropin?
-
Mechanism of Action:
- Binds to the growth hormone receptor (GHR) to activate downstream signaling.
- Triggers the JAK2–STAT pathway to regulate gene transcription involved in growth and metabolism.
- Stimulates hepatic production of insulin-like growth factor-1 (IGF-1).
- Enhances protein synthesis and amino acid uptake in muscle and other tissues.
- Promotes lipolysis by reducing triglyceride storage in adipocytes.
- Modulates glucose homeostasis in laboratory research models.
- Supports cell proliferation and tissue regeneration pathways.
-
Preclinical Studies:
Somatropin has been studied in laboratory and controlled clinical environments for its potential relevance to:
- Growth hormone deficiency (GHD) in pediatric and adult models.
- Metabolic dysfunction, including altered lipid metabolism and insulin sensitivity.
- Catabolic states associated with surgery, trauma, or chronic illness.
- Muscle wasting, sarcopenia, and age-related declines in lean mass.
- Bone density, skeletal development, and fracture-healing responses.
- Short bowel syndrome and nutrient-absorption research.
- Turner syndrome, Prader–Willi syndrome, and idiopathic short stature in growth-related studies.
- Wound healing, collagen deposition, and tissue repair mechanisms.
-
Intended Use:
- The information provided on this site is intended exclusively for educational and research purposes and should not be interpreted as medical guidance.
- Research compounds, including Somatropin, are designed solely for laboratory investigation by qualified professionals and are not intended for human use or consumption.
- The statements presented here have not been evaluated by the U.S. Food and Drug Administration, and the products discussed are not intended to diagnose, treat, cure, or prevent any disease.